Literature DB >> 27094214

Neural basis of visual perception and reasoning ability in Alzheimer's disease: correlation between Raven's Colored Progressive Matrices test and 123 I-IMP SPECT imaging results.

Taku Yoshida1, Takaaki Mori1, Hideaki Shimizu1, Yuta Yoshino1, Naomi Sonobe1, Teruhisa Matsumoto1, Keiichi Kikuchi2, Masao Miyagawa2, Junichi Iga1, Teruhito Mochizuki2, Shu-Ichi Ueno1.   

Abstract

OBJECTIVE: Impairment of visual perception frequently occurs in Alzheimer's disease (AD) and can cause severe constraints in daily activities. The nonverbal Raven's Colored Progressive Matrices (RCPM) test consists of sets A, AB, and B and is easily performed in a short time to evaluate both visual perception and reasoning ability. The purpose of this study was to evaluate the neural basis of visual perception and reasoning ability in patients with AD using RCPM and single-photon emission computed tomography (SPECT).
METHODS: Fifty patients who fulfilled the National Institute on Aging/Alzheimer's Association criteria for probable AD dementia were examined with RCPM and SPECT. All SPECTs were performed using N-isopropyl-p-[123 I]-iodoamphetamine. A multiple regression model was used to perform multivariate analyses of the relationships between regional cerebral blood flow (rCBF) and RCPM scores.
RESULTS: There was a significant positive correlation between RCPM total score and rCBF in the inferior parietal lobes bilaterally, the right inferior temporal gyrus, and the right middle frontal gyrus. Set A was positively correlated with rCBF in the right temporal and right parietal lobes. Set AB was positively correlated with rCBF in the right temporal, right parietal, and right frontal lobes. Set B was positively correlated with rCBF in the right parietal and right frontal lobes.
CONCLUSION: Our findings suggest that deteriorations of specific brain regions are associated with dysfunction of visual perception and reasoning ability in AD. RCPM is another informative assessment scale of cognition for use in patients with AD.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Alzheimer's disease; RCPM; SPECT; neuropsychological test; visual cognitive function

Mesh:

Year:  2016        PMID: 27094214     DOI: 10.1002/gps.4481

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  3 in total

1.  Vulnerability of multiple large-scale brain networks in dementia with Lewy bodies.

Authors:  Arianna Sala; Silvia Paola Caminiti; Leonardo Iaccarino; Luca Beretta; Sandro Iannaccone; Giuseppe Magnani; Alessandro Padovani; Luigi Ferini-Strambi; Daniela Perani
Journal:  Hum Brain Mapp       Date:  2019-07-19       Impact factor: 5.038

2.  Pilot Study: The Queen Square Screening Test for Visual Deficits in Dementia.

Authors:  Leah N Kim; Dennis Cordato; Alan McDougall; Clare Fraser
Journal:  Neuroophthalmology       Date:  2021-08-11

3.  Haemoglobin Concentration and Cognitive Ability in the Aberdeen Children of the 1950s.

Authors:  Mohammed T Bashir; Chris McNeil; Usman Rasul; Alison Murray
Journal:  Cureus       Date:  2022-02-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.